Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

NCT04200534 · Status: ACTIVE_NOT_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 358

Last updated 2025-08-22

No results posted yet for this study

Summary

This trial studies how well a centralized care strategy works in improving the quality of smoking cessation and shared decision making among patients who smoke and are considering lung cancer screening. The centralized care strategy is a model where smokers eligible for lung cancer screening are referred to a dedicated tobacco treatment program where they receive both the shared decision-making and initiate smoking cessation counseling prior to their visit with a primary care provider. Utilizing the centralized care model may work better in helping people quit smoking and make informed decisions about lung cancer screening compared to usual care.

Conditions

Interventions

OTHER

Best Practice

Receive usual care counseling

DRUG

Nicotine Patch

Given nicotine patches

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Tobacco Cessation Counseling

Receive counseling over the phone

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Cancer Prevention Research Institute of Texas

    collaborator OTHER
  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Robert J Volk · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
77 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-31
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04200534 on ClinicalTrials.gov